MENU
+Compare
AZN
Stock ticker: NASDAQ
AS OF
Jul 30, 04:59 PM (EDT)
Price
$76.60
Change
+$2.62 (+3.54%)
Capitalization
208.98B

AZN AstraZeneca PLC Forecast, Technical & Fundamental Analysis

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999... Show more

AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AZN with price predictions
Jul 29, 2025

AZN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for AZN moved above the 200-day moving average on July 02, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on AZN as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AZN just turned positive on July 23, 2025. Looking at past instances where AZN's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

AZN moved above its 50-day moving average on July 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AZN crossed bullishly above the 50-day moving average on July 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AZN advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where AZN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AZN broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AZN entered a downward trend on July 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.325) is normal, around the industry mean (5.632). P/E Ratio (35.297) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.870) is also within normal values, averaging (3.004). Dividend Yield (0.022) settles around the average of (0.161) among similar stocks. P/S Ratio (4.585) is also within normal values, averaging (3.643).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AZN is expected to report earnings to fall 48.85% to $1.11 per share on November 06

AstraZeneca PLC AZN Stock Earnings Reports
Q3'25
Est.
$1.11
Q2'25
Beat
by $1.08
Q1'25
Beat
by $1.39
Q4'24
Beat
by $1.03
Q3'24
Beat
by $1.06
The last earnings report on July 29 showed earnings per share of $2.17, beating the estimate of $1.09. With 10.26M shares outstanding, the current market capitalization sits at 208.98B.
A.I.Advisor
published Dividends

AZN paid dividends on March 24, 2025

AstraZeneca PLC AZN Stock Dividends
А dividend of $1.05 per share was paid with a record date of March 24, 2025, and an ex-dividend date of February 21, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
89900
Web
https://www.astrazeneca.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AAA25.02N/A
-0.02%
Alternative AccessFirstPriorityCLO BdETF
PFF31.17-0.07
-0.22%
iShares Preferred&Income Securities ETF
PFM48.82-0.20
-0.41%
Invesco Dividend Achievers™ ETF
HIGH23.29-0.12
-0.52%
Simplify Enhanced Income ETF
ILOW40.97-0.24
-0.58%
AB Active ETFs Inc.

AZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with NVS. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+3.53%
NVS - AZN
61%
Loosely correlated
+0.39%
GSK - AZN
59%
Loosely correlated
+3.45%
AZNCF - AZN
48%
Loosely correlated
+3.45%
PFE - AZN
47%
Loosely correlated
-2.02%
SNY - AZN
47%
Loosely correlated
-0.20%
More